Invatec Receives FDA Clearance For Mo.Ma(R) Ultra Proximal Cerebral Protection Device

Main Category: Neurology / Neuroscience Also Included In: Regulatory Affairs / Drug Approvals ; Medical Devices / Diagnostics ; Stroke Article Date: 23 Oct 200919:00 PDT Invatec, a comprehensive innovator of interventional products, announced that it has received 510 clearance from the U.S. Food and Drug Administration to market its Mo.Ma Ultra …

source : www.topix.com

Related News:

• Paloma Pharmaceuticals Receives Approval To Enter Phase I Clinical Trials
• Pervasis Therapeutics Receives FDA Clearance For Pivotal Phase 3 Trial Of Vascugel(R)
• Repros Receives Guidance From FDA Regarding Continued Development Of Androxal(R) In Hypogonadal Men
• Teva Receives Favorable Court Decision Regarding Generic Temodar(R)
• Glaucoma Research: IU Optometry’s Swanson Receives $2.35 Million From NIH
• Amgen Receives CHMP Positive Opinion For Prolia(TM) (Denosumab) In The European Union
• Nasal-AireR II Petite Receives FDA 510k learance For Pediatric Use
• Presbia’s Flexivue™ icro-Lens Receives uropean arket Approval
• University Of California, San Francisco, Researcher Receives ASBMB-Merck Award
• Presbia’s Flexivue™ Micro-Lens Receives European Market Approval

Details :
Submited at Saturday, October 24th, 2009 at 12:00 pm on Neurology by admin
Comment RSS 2.0 - leave a comment - trackback